Helix BioPharma Corp. reported earnings results for the first quarter ended October 31, 2021. For the first quarter, the company reported net loss was CAD 1.81 million compared to CAD 0.222 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago. Basic loss per share was CAD 0.01.